I understand that a group of women who received infectious, or potentially infectious, Anti-D Immunoglobulin in two periods (between 1977 and 1979 and between 1991 and 1994) and who tested negative for Hepatitis C are seeking access to claim compensation from the Hepatitis C and HIV Compensation Tribunal and to be awarded HAA cards.
The Hepatitis C Compensation Tribunal (Amendment) Act 2006 restricts access to the Tribunal to those people who have been diagnosed with Hepatitis C or HIV, and provides clear scientific grounds for the definition of “diagnosed positive for Hepatitis C”. Under this legislation a diagnosis must arise (a) from a positive result from one of three specific tests for the presence of Hepatitis C virus, or (b) from the presence of antibodies to the virus, or (c) based on evidence of jaundice up to 16 weeks after the administration of Anti-D Immunoglobulin. I am satisfied that no new scientific evidence has emerged in this regard.
It is estimated that up to 16,000 women in Ireland were exposed to potentially infectious batches of Anti-D. Approximately 1,000 of these women were infected with Hepatitis C and were therefore eligible to apply to the Tribunal for compensation.